Podiatrists in Brattleboro, VT Accepting Medicare

5 Podiatrists found. Showing 1 - 5

Dr. Ethan Andrew Buhl, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 19 Belmont Ave Ofc Building, Brattleboro, VT 05301 Phone: 802-251-8650

Southern Vermont Podiatry Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 382 Canal St, Brattleboro, VT 05301 Phone: 802-254-0202    Fax: 802-246-1300

David Liebow, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 382 Canal St, Brattleboro, VT 05301 Phone: 802-254-0202    Fax: 802-246-1300

Kimberly Liebow, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 382 Canal St, Brattleboro, VT 05301 Phone: 802-254-0202    Fax: 802-246-1300

Dr. Raymond Leo Mariani, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 142 Western Ave, Brattleboro, VT 05301 Phone: 802-257-7913    Fax: 802-257-7913

News Archive

Women using short-acting asthma relievers take longer to become pregnant, study shows

Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to international research led by the University of Adelaide.

Ovarian serous cancer patients with overexpression of HER4 protein less likely respond to chemotherapy

Moffitt Cancer Center researchers discovered that patients with ovarian serous cancer and an overexpression of the HER4 protein are less likely to respond to chemotherapy and have a lower rate of survival.

Zinc acetate and zinc gluconate lozenges show similar efficacy in shortening duration of common colds

There is no significant difference between zinc acetate lozenges and zinc gluconate lozenges regarding their efficacy in shortening the duration of common colds according to a meta-analysis published in Journal of the Royal Society of Medicine Open.

Phase 1/2 clinical trial data of Oncophage for recurrent high-grade glioma

Antigenics today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco.

New report recommends dental schools to follow specific steps for successful mentoring programs

A new report by an Indiana University School of Dentistry department chair with researchers from six other U.S. dental schools is calling for quick and creative solutions to address the growing scarcity of full-time faculty members within the nation's dental school programs.

Read more Medical News

› Verified 8 days ago